Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

Citations Over TimeTop 1% of 2006 papers

Abstract

Pathological gambling (PG) related to dopaminergic treatment in Parkinson's disease (PD) is part of a spectrum of behavioral disorders called the dopamine dysregulation syndrome (DDS). We describe a series of PD patients with preoperative active PG due to dopaminergic treatment from a total of 598 patients who have undergone surgery for subthalamic nucleus stimulation for disabling motor fluctuations. The patients had systematic open assessment of behavioral symptoms and standardized assessments of motor symptoms, mood, and apathy. Seven patients (6 men, 1 woman; age, 54 +/- 9 years; levodopa equivalent dose, 1,390 +/- 350 mg/day) had preoperative PG over a mean of 7 years, intolerant to reduction in medication. Six had nonmotor fluctuations and four had other behavioral symptoms consistent with a diagnosis of the DDS. After surgery, motor symptoms improved, allowing for 74% reduction of dopaminergic treatment, below the dosage of gambling onset. In all patients, PG resolved postoperatively after 18 months on average (range, 0-48), although transient worsening occurred in two. Improvement paralleled the time course and degree of reduction in dopaminergic treatment. Nonmotor fluctuations, off period dysphoria, and other symptoms of the DDS improved. Two patients developed persistent apathy. In conclusion, PG and other symptoms of the DDS-associated dopaminergic treatment improved in our patients following surgery. Dopaminergic dysregulation commonly attributed to pulsatile overstimulation of the limbic dopaminergic system may be subject to desensitization on chronic subthalamic stimulation, which has a relative motor selectivity and allows for decrease in dopaminergic treatment.

Related Papers

• → Deep brain stimulation of the subthalamic nucleus improves sense of well‐being in parkinson's disease(2012)20 cited
• → Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal(2011)2 cited
• → Various targeting methods for subthalamic nucleus in deep brain stimulation(2019)1 cited
• → Post-Mortem Analysis of Parkinson’s Disease Brains After 11 and 12 Years of Deep Brain Stimulation of the Subthalamic Nucleus(2022)1 cited
• → PO061 / #228 LONG-TERM OUTCOME OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION FOR PARKINSON’S DISEASE: 10 YEARS AND BEYOND(2022)